etoricoxib (MK0663) 120 mg + Comparator: Placebo + etoricoxib (MK0663) 90 mg
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 34/100
34
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Acute Pain Following a Total Abdominal Hysterectomy
Conditions
Acute Pain Following a Total Abdominal Hysterectomy
Trial Timeline
Oct 1, 2008 → Jul 1, 2010
NCT ID
NCT00788710About etoricoxib (MK0663) 120 mg + Comparator: Placebo + etoricoxib (MK0663) 90 mg
etoricoxib (MK0663) 120 mg + Comparator: Placebo + etoricoxib (MK0663) 90 mg is a phase 3 stage product being developed by Organon for Acute Pain Following a Total Abdominal Hysterectomy. The current trial status is completed. This product is registered under clinical trial identifier NCT00788710. Target conditions include Acute Pain Following a Total Abdominal Hysterectomy.
What happened to similar drugs?
20 of 20 similar drugs in Acute Pain Following a Total Abdominal Hysterectomy were approved
Approved (20) Terminated (4) Active (0)
✅Modification of Prasugrel based on a biological assay + prasugrel / clopidogrelDaiichi SankyoApproved
Hype Score Breakdown
Clinical
17
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00788710 | Phase 3 | Completed |
Competing Products
20 competing products in Acute Pain Following a Total Abdominal Hysterectomy